Sponsor Pipeline

Arovella Therapeutics Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07518329 Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. Non Hodgkin Lymphoma (NHL) Not Yet Recruiting
Disease Areas
Leukemia (1) Non-Hodgkin Lymphoma (1)
Get alerts when Arovella Therapeutics Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free